01.12.2014 Views

September/October - West Virginia State Medical Association

September/October - West Virginia State Medical Association

September/October - West Virginia State Medical Association

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

| Scientific Article<br />

Methods<br />

Approval was obtained from<br />

the Institutional Review Board<br />

before beginning our research.<br />

A retrospective chart review<br />

was performed on patients seen<br />

at University Obstetrics and<br />

Gynecology office and the Cabell<br />

Huntington Hospital Obstetrics<br />

and Gynecology clinic from May<br />

2005-November 2007. We included<br />

patients ≤25 years of age tested for<br />

CT using endocervical Gen-Probe at<br />

their initial prenatal visit and again<br />

at 34-36 weeks gestation. Gen-Probe<br />

PACE 2C system is a rapid DNA<br />

probe test which utilizes nucleic<br />

acid hybridization to screen for the<br />

presence of CT. The sensitivity is<br />

92.6 and specificity 99.810. Results<br />

of the CT testing from the initial<br />

visit and the 34-36 week visit were<br />

recorded. Patients were excluded<br />

if they were >25 years old or did<br />

not have both the initial CT testing<br />

as well as the 34-36 week test.<br />

Results<br />

One hundred eighty one (181)<br />

patients were included in the study.<br />

On the initial screen 175 patients<br />

tested negative for CT. Six patients<br />

tested positive for CT on the initial<br />

screen and were treated. At 34-<br />

36 weeks, of the 175 patients that<br />

originally tested negative, 170 tested<br />

negative again and 5 tested positive<br />

for CT. Of the six patients who tested<br />

positive at the initial screen, 5 were<br />

negative and 1 remained positive at<br />

the 34-36 week screen. See figure 1.<br />

A chi squared test of statistical<br />

significance was performed on the<br />

data. P-value was >0.05 meaning that<br />

having a negative initial screen was<br />

not predictive of having a negative<br />

result upon re-testing at 34-36 weeks.<br />

Discussion<br />

The results of our study indicate<br />

that first trimester Chlamydia<br />

trachomatis test results are not<br />

predictive of CT status during<br />

the third trimester. This finding<br />

was contrary to our hypothesis of<br />

re‐screening for CT during the 3rd<br />

trimester is probably of low yield.<br />

The risk of complications in<br />

the newborn due to maternal CT<br />

infection is significant. An infant<br />

born to an infected mother has a<br />

50-70% chance of acquiring the<br />

infection during a vaginal delivery. 4<br />

Neonatal conjunctivitis occurs<br />

in 20-50% of exposed infants. 5<br />

Unrecognized neonatal conjunctivitis<br />

may persist for months and cause<br />

corneal and conjunctival scarring. 8<br />

Pneumonia develops in 10-20%<br />

of exposed infants. 5 This infection<br />

causes fever and cough that interfere<br />

with feeding. Respiratory distress<br />

may also result. If left untreated,<br />

pneumonia caused by CT can result<br />

in chronic pulmonary disease. 4 There<br />

is conflicting evidence regarding the<br />

association of CT with preterm labor. 3<br />

It has been demonstrated that<br />

screening for and treating CT<br />

infections decreases neonatal and<br />

postnatal complications. 6,7 During<br />

the study period, new guidelines<br />

were published that recommended<br />

repeat testing during the 3rd<br />

trimester for all patients ≤25 years<br />

old and those at high-risk of<br />

acquiring CT. 9 The results of our<br />

study support this recommendation.<br />

In light of the significant neonatal<br />

and postnatal complications, as<br />

well as a lack of evidence linking<br />

CT with preterm labor, it is just as<br />

important, if not more important,<br />

to screen for Chlamydia trachomatis<br />

during the third trimester rather<br />

than the first trimester.<br />

References<br />

1. Center for Disease Control. 2006 STD<br />

Surveillance Report.<br />

2. United <strong>State</strong>s Preventative Services Task<br />

Force Guidelines: Screening for chlamydial<br />

infection.<br />

3. Andrews, et al. Midpregnancy<br />

genitourinary tract infection with Chlamydia<br />

trachomatis: association with subsequent<br />

preterm delivery in women with bacterial<br />

vaginosis and Trichomonas vaginalis.<br />

American Journal of Obstetrics and<br />

Gynecology; 2006.194:493.<br />

4. Zar, H.J. Neonatal Chlamydial Infections.<br />

Pediatric Drugs, 2005;7(2):103-10.<br />

5. Remington and Klein. Infectious Disease of<br />

the Fetus and Newborn, 5th edition. 2001.<br />

W.B. Saunders Company. p770.<br />

6. Rours, et al. Sexually Transmitted Infection<br />

2006.<br />

7. Ismail, et al. Role of Chlamydia<br />

trachomatis in postpartum endometritis.<br />

Journal of Reproductive Medicine, 1987<br />

April;32(4):280-4.<br />

8. Forester, et al. Late follow-up of patients<br />

with neonatal inclusion conjunctivitis.<br />

American Journal of Opthomology. 1970;<br />

69:467.<br />

9. American Academy of Pediatrics and<br />

American College of Obstetrics and<br />

Gynecologists. Guidelines for Perinatal<br />

Care. 6th edition. 2007.<br />

10. Gen-Probe PACE 2C System Package<br />

Insert.<br />

11. Weinstock, H, Berman, S, Cates, W, Jr.<br />

Sexually Transmitted Diseases among<br />

American Youth: Incidence and Prevalence<br />

Estimates, 2000. Perspect Sex Reprod<br />

Health, 2004:36(1):6-10.<br />

<strong>September</strong>/<strong>October</strong> 2010 | Vol. 106 11

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!